Sønnichsen-Dreehsen Anne-Sofie, Fedder Jens, Wod Mette, Thorarinsson Caroline Thingholm, Nørgård Bente Mertz
Centre of Andrology & Fertility Clinic, Odense University Hospital & University of Southern Denmark, Odense, Denmark.
Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark.
Andrology. 2025 Mar;13(3):485-493. doi: 10.1111/andr.13702. Epub 2024 Jul 30.
About 15% of all pregnancies end in pregnancy loss. As most studies have focused on maternal factors little is known regarding the influence of paternal factors on the chance of successful pregnancy.
This cohort study aims to assess the chance of biochemical pregnancy, clinical pregnancy, and live-born children in couples where the male partner has diabetes mellitus (DM).
We performed a nationwide cohort study. Couples undergoing assisted reproductive technology treatment from 2006 to 2019 were included. The exposed cohorts comprised embryo transfers in couples with paternal type 1 DM (T1DM), type 2 DM (T2DM), or mixed type DM (TMDM). The unexposed cohort included embryo transfers in couples without paternal DM.
A total of 101,875 embryo transfers were included. Of these, 503 males had T1DM, 225 males had T2DM, 263 males had TMDM, and 100,884 did not have DM. For paternal T1DM, the adjusted OR for achieving a biochemical pregnancy, clinical pregnancy, and live-born child were 0.97 (95% CI 0.77-1.23), 1.08 (95% CI 0.65-1.79), and 0.75 (95% CI 0.49-1.14), respectively. For paternal T2DM, the adjusted OR for achieving a biochemical pregnancy, clinical pregnancy, and live-born child were 0.80 (95% CI 0.56;1.16), 0.67 (95% CI 0.32-1.41), and 1.03 (95% CI 0.48-2.20), respectively. For the paternal TMDM, the adjusted OR for achieving a biochemical pregnancy, clinical pregnancy and livebirth were 0.95 (95% CI 0.67-1.33), 1.31 (95% CI 0.56-2.92), and 1.19 (95% CI 0.59-2.38), respectively.
Paternal DM was not associated with a statistically significant decreased chance of biochemical pregnancy, clinical pregnancy, or live birth.
约15%的妊娠以流产告终。由于大多数研究都集中在母体因素上,关于父体因素对成功妊娠几率的影响知之甚少。
这项队列研究旨在评估男性伴侣患有糖尿病(DM)的夫妇发生生化妊娠、临床妊娠和活产儿的几率。
我们进行了一项全国性队列研究。纳入了2006年至2019年接受辅助生殖技术治疗的夫妇。暴露队列包括父体1型糖尿病(T1DM)、2型糖尿病(T2DM)或混合型糖尿病(TMDM)夫妇的胚胎移植。未暴露队列包括父体无糖尿病夫妇的胚胎移植。
共纳入101,875次胚胎移植。其中,503名男性患有T1DM,225名男性患有T2DM,263名男性患有TMDM,100,884名男性无糖尿病。对于父体T1DM,实现生化妊娠、临床妊娠和活产儿的校正比值比分别为0.97(95%CI 0.77-1.23)、1.08(95%CI 0.65-1.79)和0.75(95%CI 0.49-1.14)。对于父体T2DM,实现生化妊娠、临床妊娠和活产儿的校正比值比分别为0.80(95%CI 0.56;1.16)、0.67(95%CI 0.32-1.41)和1.03(95%CI 0.48-2.20)。对于父体TMDM,实现生化妊娠、临床妊娠和活产的校正比值比分别为0.95(95%CI 0.67-1.33)、1.31(95%CI 0.56-2.92)和1.19(95%CI 0.59-2.38)。
父体糖尿病与生化妊娠、临床妊娠或活产几率的统计学显著降低无关。